Home

Yu-Waye Chu, Chief Medical Officer: CytomX Therapeutics CTMX Sell · Filed 25/03/20

Trade details

Type
Insider sale
Amount
$2,415
Shares · price
4,025 sh · $0.60 a share
Held after
135,725 sh
Trade date
25/03/18
Filed
25/03/20
Days to filing
2 days

Sold 2.9% of holdings

Share of holding sold
2.9%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Yu-Waye Chu's recent trades

  • Yu-Waye Chu

    SellCytomX Therapeutics

    $136.6K

    Filed 03/19

  • Yu-Waye Chu

    Sell10b5-1 planFate Therapeutics

    $15.2K

    Filed 23/04/19

  • Yu-Waye Chu

    Sell10b5-1 planFate Therapeutics

    $1,402

    Filed 23/04/19

  • Yu-Waye Chu

    SellFate Therapeutics

    $41K

    Filed 23/01/11

Yu-Waye Chu, Chief Officer — sold $2,415 of CytomX Therapeutics CTMX · 2.9% of holdings | Whalegun